Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Mol Immunol. 2012 Jun 29;52(3-4):242–248. doi: 10.1016/j.molimm.2012.06.005

Fig. 1.

Fig. 1

The CRP promoter and the oligos used in this study. (A) The −300 to +3 region of the CRP gene is shown. The binding sites of various transcription factors on the promoter are boxed. (B) Sequences of the oligos derived from the CRP promoter and used as probes in EMSA. (C) Sequences of the mutagenic oligos used for mutagenesis of the CRP promoter to construct the m-Oct promoter.